The Medical Devices sector report, “Left Ventricular Assist Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Left Ventricular Assist Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. It assists the left ventricle by pumping oxygenated blood to the body. It can also be used to treat the right ventricle in some cases.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. It assists the left ventricle by pumping oxygenated blood to the body. It can also be used to treat the right ventricle in some cases.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Left Ventricular Assist Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Left Ventricular Assist Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Left Ventricular Assist Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Left Ventricular Assist Devices - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Vascular Inc
- Abiomed Inc
- APK Advanced Medical Technologies, Inc.
- Arrow International Cr, A.S.
- Beijing Yuewei Medical Technology Co Ltd
- BioVentrix Inc
- BrioHealth Solutions Inc
- Calon Cardio-Technology Ltd
- Cardiac Success Ltd
- CardiacBooster BV
- CARDIAnove Inc
- Carnegie Mellon University
- Chongqing Yongrenxin Medical Devices Co Ltd
- Cleveland Clinic Hospital
- Cleveland Heart Inc
- CorAssist Cardiovascular Ltd
- Corvion Inc
- CorWave SA
- Duke University
- FineHeart
- Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
- Griffith University
- HeartWare International Inc
- Indian Institute of Technology, Kanpur
- Inspired Therapeutics LLC
- Jarvik Heart Inc
- LaunchPoint Technologies Inc
- Leviticus Cardio Ltd
- Levram Medical Systems Ltd
- Magenta Medical Ltd
- Mayo Clinic
- Medtronic Plc
- Nipro Corp
- Percassist Inc
- Perfusion Solution Inc
- PlugMed Heart SAS
- Pumpinheart Ltd
- ReliantHeart, Inc.
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Sun Medical Technology Research Corp
- Sunshine Heart Company, Pty. Ltd.
- Suzhou LungShield Medical Tech Co Ltd
- Syntach AB
- Thoratec LLC
- Tokyo Medical and Dental University
- U.S. Stem Cell Inc
- University of Virginia
- VASCOR Inc
- Windmill Cardiovascular Systems, Inc.
- W-Z BIOTECH, LLC
- Yale University